Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
GLGalapagos N.V. logo

Galapagos N.V. (GLPG)

NASDAQ · Currency in USD
$27.98 ▲ +0.47 (+1.71%)
At close: Jun 4, 11:58 AM ET. Market closed.

Summary

Previous Close
$27.51
Open
$27.50
Day's Range
$27.50 – $28.09
52 Week Range
$24.74 – $37.78
Volume
2,385
Avg. Volume
153,204
Market Cap
$1.84B
Beta (5Y Monthly)
0.30
PE Ratio (TTM)
2.77
EPS (TTM)
$8.52
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$67.93

Profile: Galapagos N.V.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
452
CEO
Henry O. Gosebruch

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Earnings

DateEst.Actual
May 6, 2026-$1.27$0.25Beat
Feb 23, 2026$1.00$16.38Beat
Nov 5, 2025-$0.20-$3.59Miss
Jul 23, 2025-$0.67-$1.89Miss
Apr 23, 2025-$0.23-$2.47Miss
Feb 28, 2025-$0.24$0.39Beat

Analyst view

Consensus price target
$67.93 ▲ +142.8%
Range $33.00 – $97.00
Rating: Hold
Buy 38% · Hold 46% · Sell 17%

Get free alerts on GLPG and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.